• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Monte Rosa Therapeutics Inc (NQ: GLUE )

    4.497 -0.063 (-1.39%)
    Streaming Delayed Price Updated: 12:41 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 61,303
    Open 4.490
    Bid (Size) 4.490 (1)
    Ask (Size) 4.510 (1)
    Prev. Close 4.560
    Today's Range 4.460 - 4.700
    52wk Range 2.440 - 8.840
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -21.25%
    -21.25%
    1 Month
    +18.02%
    +18.02%
    3 Month
    -18.84%
    -18.84%
    6 Month
    -19.85%
    -19.85%
    1 Year
    -36.22%
    -36.22%

    More News

    Read More
    Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Monte Rosa Therapeutics Announces Leadership Team Promotions
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    GLUE Stock Earnings: Monte Rosa Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7 Directed Molecular Glue Degrader and NLRP3/IL-1β Pathway Inhibitor
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street
    Via The Motley Fool
    Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Monte Rosa Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Monte Rosa Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.